SEC Form 4 · accession 0001209191-18-038655
Outlook Therapeutics, Inc. · OTLK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen J McAndrew
Officer — SVP Bus. Strat. & Dev.
Period of report
Jun 15, 2018
Accepted (ET)
Jun 19, 2018 · 6:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001649989
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.90 | Jun 15, 2018 | A | 30,000 | A | — | Jun 15, 2028 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1The shares underlying the option shall vest in three equal installments beginning on June 15, 2019 such that the option shall be vested in full on June 15, 2021, subject to the Reporting Person providing continuous service to the Issuer on each such date.